Iron Triangle Partners LP - Q3 2020 holdings

$447 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 45.8% .

 Value Shares↓ Weighting
EHC BuyENCOMPASS HEALTH CORP$45,334,000
+33.1%
697,659
+26.8%
10.13%
+18.1%
ZBH BuyZIMMER BIOMET HOLDINGS INC$29,951,000
+258.5%
220,000
+214.3%
6.69%
+218.1%
CRL  CHARLES RIV LABS INTL INC$29,439,000
+29.9%
130,0000.0%6.58%
+15.3%
HZNP SellHORIZON THERAPEUTICS PUB L$27,188,000
+12.2%
350,000
-19.7%
6.08%
-0.5%
CTLT  CATALENT INC$23,985,000
+16.9%
280,0000.0%5.36%
+3.7%
HOLX SellHOLOGIC INC$23,785,000
-16.5%
357,833
-28.4%
5.32%
-25.9%
BSX  BOSTON SCIENTIFIC CORP$22,926,000
+8.8%
600,0000.0%5.12%
-3.4%
NVRO BuyNEVRO CORP$22,288,000
+24.0%
160,000
+6.3%
4.98%
+10.0%
IQV BuyIQVIA HLDGS INC$22,068,000
+13.1%
140,000
+1.8%
4.93%
+0.3%
PACB NewPACIFIC BIOSCIENCES CALIF IN$19,740,0002,000,000
+100.0%
4.41%
DVA NewDAVITA INC$18,843,000220,000
+100.0%
4.21%
GH BuyGUARDANT HEALTH INC$18,555,000
+38.2%
166,000
+0.3%
4.15%
+22.6%
MOH  MOLINA HEALTHCARE INC$18,304,000
+2.8%
100,0000.0%4.09%
-8.7%
INOV SellINOVALON HLDGS INC$17,193,000
+21.8%
650,000
-11.3%
3.84%
+8.0%
SGRY BuySURGERY PARTNERS INC$16,425,000
+109.8%
750,000
+10.8%
3.67%
+86.1%
ANTM NewANTHEM INC$16,115,00060,000
+100.0%
3.60%
AXNX SellAXONICS MODULATION TECHNOLOG$15,475,000
+26.8%
303,201
-12.8%
3.46%
+12.5%
VCEL NewVERICEL CORP$10,747,000580,000
+100.0%
2.40%
BMY SellBRISTOL-MYERS SQUIBB CO$9,044,000
-46.5%
150,000
-47.9%
2.02%
-52.6%
INSP SellINSPIRE MED SYS INC$9,034,000
-10.5%
70,000
-39.7%
2.02%
-20.6%
TWST SellTWIST BIOSCIENCE CORP$7,597,000
-60.1%
100,000
-76.2%
1.70%
-64.6%
OM NewOUTSET MED INC$7,500,000150,000
+100.0%
1.68%
NVST SellENVISTA HOLDINGS CORPORATION$7,404,000
-29.8%
300,000
-40.0%
1.66%
-37.7%
BLFS NewBIOLIFE SOLUTIONS INC$4,341,000150,000
+100.0%
0.97%
RPRX  ROYALTY PHARMA PLC$4,207,000
-13.3%
100,0000.0%0.94%
-23.1%
ADPT ExitADAPTIVE BIOTECHNOLOGIES COR$0-150,000
-100.0%
-1.83%
BMY ExitBRISTOL-MYERS SQUIBB COcall$0-200,000
-100.0%
-2.96%
CHNG ExitCHANGE HEALTHCARE INC$0-1,147,800
-100.0%
-3.24%
MCK ExitMCKESSON CORP$0-85,000
-100.0%
-3.28%
BAX ExitBAXTER INTL INC$0-330,000
-100.0%
-7.16%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings